Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL732857 | 0.86 | TSHR (0.56) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL5440894 | 0.83 | TSHR (0.48) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| Glycidol SCHEMBL27421221 | 0.81 | TSHR (0.54) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL28812806 | 0.80 | TSHR (0.54) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL730829 | 0.80 | TSHR (0.54) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL50196 | 0.80 | TSHR (0.54) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL4313158 | 0.80 | TSHR (0.54) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| Cyclopentane SCHEMBL9803711 | 0.79 | TSHR (0.52) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| Ethylene Glycol SCHEMBL729874 | 0.79 | TSHR (0.52) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| Ethylene Glycol SCHEMBL9187201 | 0.79 | TSHR (0.52) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3735433-A1 | EPOXY RESIN COMPOSITION FOR COATING PURPOSES | SIKA TECHNOLOGY AG (CH) | 2020-11-11 | — | — | EP | claimed |
| CN-111732933-A | High-strength high-hardness epoxy modified MS sealant and preparation method thereof | 迪马新材料科技（苏州）有限公司 | 2020-10-02 | — | — | CN | claimed |
| WO-2019134821-A1 | EPOXY RESIN COMPOSITION FOR COATING PURPOSES | SIKA TECHNOLOGY AG (CH) | 2019-07-11 | — | — | WO | claimed |
| US-8262895-B2 | Plating bath and method | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2012-09-11 | — | — | US | claimed |
| CN-111886525-B | Active energy ray-curable resin composition, polarizing film protective layer, and polarizing plate | 三菱化学株式会社 | 2023-03-28 | — | — | CN | disclosed |
| WO-2023286873-A1 | MULTILAYER BODY AND ELECTRONIC DEVICE THAT IS PROVIDED WITH MULTILAYER BODY | 太陽インキ製造株式会社 | 2023-01-19 | — | — | WO | disclosed |
| WO-2023286872-A1 | LAMINATE AND ELECTRONIC DEVICE PROVIDED WITH LAMINATE | 太陽インキ製造株式会社 | 2023-01-19 | — | — | WO | disclosed |
| CN-111732933-B | High-strength high-hardness epoxy modified MS sealant and preparation method thereof | 迪马新材料科技（苏州）有限公司 | 2020-12-22 | — | — | CN | disclosed |
| CN-111886525-A | Active energy ray-curable resin composition, polarizing film protective layer, and polarizing plate | 三菱化学株式会社 | 2020-11-03 | — | — | CN | disclosed |
| CN-111732933-A | High-strength high-hardness epoxy modified MS sealant and preparation method thereof | 迪马新材料科技（苏州）有限公司 | 2020-10-02 | — | — | CN | disclosed |
| EP-2562294-B1 | PLATING BATH AND METHOD | ROHM & HAAS ELECT MAT (US) | 2019-09-25 | — | — | EP | disclosed |
| US-9624380-B2 | Sulfide extended epoxy resins and barrier coating applications thereof | SUN CHEMICAL CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-7910666-B2 | Mercaptan-hardened epoxy polymer compositions and processes for making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2011-03-22 | — | — | US | disclosed |
| WO-2011008480-A1 | POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING SAME | POLYMERIGHT, INC. (US) | 2011-01-20 | — | — | WO | disclosed |
| WO-2009132010-A1 | METHODS AND SYSTEMS FOR MAKING THIOL COMPOUNDS FROM TERMINAL OLEFINIC COMPOUNDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-29 | — | — | WO | disclosed |
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-22 | — | — | US | disclosed |
| EP-1940992-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2008-07-09 | — | — | EP | disclosed |
| US-20070112100-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY, LP | 2007-05-17 | — | — | US | disclosed |
| WO-2007022217-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2007-02-22 | — | — | WO | disclosed |
| US-6538046-B1 | Acrylated resin, amine, diamine or polyamine, hydroxyl compound and diisocyanate; coatings for wood or leather | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | TST, HHAT, GSTO1 | TSHR 4571/4885TP53 1519/4885CYP3A4 793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.